(Total Views: 495)
Posted On: 08/14/2021 8:26:34 AM
Post# of 22443
You're jumping to conclusions.
I do not see how you get from lateral flow QD tests to saying QMC wants to do molecular imaging of QD for cancers in the body. The clinical trials for that will take forever. This is a trial of 5 patients. Does that even qualify as Phase One?
I can imagine Dr Malan at innova doing something like that, and QMC might supply QD to them, but that's all. I hope QMC supplies QD to all the thousands of Biomed companies,
BTW, on the same website, Perdue U is doing similar work. There's lots of room for competition, as you say, but doesn't mean they have to play. Clinical trials take too long. FDA for simple tests is hard enough lol.
Purdue U article-
https://www.laserfocusworld.com/biooptics/bio...vity-study
I do not see how you get from lateral flow QD tests to saying QMC wants to do molecular imaging of QD for cancers in the body. The clinical trials for that will take forever. This is a trial of 5 patients. Does that even qualify as Phase One?
I can imagine Dr Malan at innova doing something like that, and QMC might supply QD to them, but that's all. I hope QMC supplies QD to all the thousands of Biomed companies,
BTW, on the same website, Perdue U is doing similar work. There's lots of room for competition, as you say, but doesn't mean they have to play. Clinical trials take too long. FDA for simple tests is hard enough lol.
Purdue U article-
https://www.laserfocusworld.com/biooptics/bio...vity-study
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)